Regulus Therapeutics
RGLS
#8767
Rank
โ‚น8.12 B
Marketcap
โ‚น124.04
Share price
-0.68%
Change (1 day)
12.81%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น0.73 B50.2%
2019 โ‚น0.48 B9577.32%
2018 โ‚น5.03 M9.51%
2017 โ‚น4.59 M-94.33%
2016 โ‚น81.13 M-94.12%
2015 โ‚น1.37 B183.83%
2014 โ‚น0.48 B-59.8%
2013 โ‚น1.20 B73.86%
2012 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น3.396 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.514 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น816.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.145 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น176.75 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.03 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.002 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.27 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA